13 January 2026
Latham Advises on Arrowhead Pharmaceuticals Upsized Offerings of US$625 Million Convertible Senior Notes, and US$200 Million Common Stock and Pre-Funded Warrants
Advising firms
Deal team
15 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Bush Lead | Latham & Watkins LLP | Partner | Capital Markets | San Diego |
| Greg Rodgers Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Arash Aminian Baghai Lead | Latham & Watkins LLP | Partner | Capital Markets | Los Angeles |
| Anthony Gostanian | Latham & Watkins LLP | Counsel | Capital Markets | San Diego |
| Andrew Bentz | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Omeed Valipour | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Sterling Swift | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Steve Hess | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Ariana Alemi | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Catherine Lee | Latham & Watkins LLP | Partner | derivatives | New York |
| Christopher Yu | Latham & Watkins LLP | Counsel | derivatives | Not stated |
| Adam Zhang | Latham & Watkins LLP | Associate | derivatives | Not stated |
| Rebecca Kientz | Latham & Watkins LLP | Not stated | derivatives | Not stated |
| Elena Romanova | Latham & Watkins LLP | Partner | tax | New York |
| Jack Santoro | Latham & Watkins LLP | Associate | tax | Not stated |
12 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 625m (US$625 million)
- What the figure measures
- Issue size
- Client
- Arrowhead Pharmaceuticals, Inc.Issuer
- Counterparties
- Not stated